{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:19:13Z","timestamp":1789258753488,"version":"build-2803163510"},"reference-count":32,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,6]]},"DOI":"10.14797\/mdcvj.1122","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T12:08:51Z","timestamp":1662466131000},"page":"34-40","source":"Crossref","is-referenced-by-count":17,"title":["Kidney Disease after Heart and Lung Transplantation"],"prefix":"10.14797","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-5117","authenticated-orcid":false,"given":"Carlos M.","family":"Zapata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1567-9592","authenticated-orcid":false,"given":"Hassan N.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5826","reference":[{"issue":"10","key":"key20220906080845_B1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","year":"2003","journal-title":"N Engl J Med"},{"issue":"9","key":"key20220906080845_B2","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/j.1600-6143.2006.01458.x","article-title":"Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation","volume":"6","year":"2006","journal-title":"Am J Transplant"},{"issue":"24","key":"key20220906080845_B3","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","year":"2003","journal-title":"N Engl J Med"},{"issue":"7\u20138","key":"key20220906080845_B4","first-page":"385","article-title":"Predictive performance of different kidney function estimation equations in lung transplant patients","volume":"50","year":"2017","journal-title":"Clin Biochem"},{"issue":"2","key":"key20220906080845_B5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/lt.20017","article-title":"Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations","volume":"10","year":"2004","journal-title":"Liver Transpl"},{"issue":"10","key":"key20220906080845_B6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/jcm8101713","article-title":"Acute Kidney Injury after Lung Transplantation: A Systematic Review and Meta-Analysis","volume":"8","year":"2019","journal-title":"J Clin Med"},{"issue":"5","key":"key20220906080845_B7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/TP.0000000000002023","article-title":"Influence of Blood Pressure and Calcineurin Inhibitors on Kidney Function After Heart or Liver Transplantation","volume":"102","year":"2018","journal-title":"Transplantation"},{"issue":"12","key":"key20220906080845_B8","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.healun.2006.09.023","article-title":"Predictors of decline in renal function after lung transplantation","volume":"25","year":"2006","journal-title":"J Heart Lung Transplant"},{"issue":"8","key":"key20220906080845_B9","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.transproceed.2010.05.064","article-title":"Chronic kidney disease after lung transplantation: incidence, risk factors, and treatment","volume":"42","year":"2010","journal-title":"Transplant Proc"},{"issue":"3","key":"key20220906080845_B10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/ki.2014.298","article-title":"Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria","volume":"87","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"key20220906080845_B11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00041552-199805000-00005","article-title":"Chronic cyclosporine nephrotoxicity","volume":"7","year":"1998","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"key20220906080845_B12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy","volume":"311","year":"1984","journal-title":"N Engl J Med"},{"issue":"9225","key":"key20220906080845_B13","first-page":"194","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study","volume":"356","year":"2000","journal-title":"The Rapamune US Study Group. Lancet"},{"issue":"9","key":"key20220906080845_B14","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/j.1600-6143.2005.01019.x","article-title":"Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus","volume":"5","year":"2005","journal-title":"Am J Transplant"},{"issue":"25","key":"key20220906080845_B15","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","year":"2007","journal-title":"N Engl J Med"},{"issue":"3","key":"key20220906080845_B16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1600-6143.2005.01177.x","article-title":"Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus","volume":"6","year":"2006","journal-title":"Am J Transplant"},{"issue":"8","key":"key20220906080845_B17","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1097\/TP.0b013e31816a8ae6","article-title":"Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus","volume":"85","year":"2008","journal-title":"Transplantation"},{"issue":"8","key":"key20220906080845_B18","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1600-6143.2011.03573.x","article-title":"The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"issue":"1","key":"key20220906080845_B19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/TP.0b013e3182394cb3","article-title":"Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal","volume":"93","year":"2012","journal-title":"Transplantation"},{"issue":"3","key":"key20220906080845_B20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"key20220906080845_B21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"issue":"5","key":"key20220906080845_B22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1600-6143.2009.02615.x","article-title":"Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"8","key":"key20220906080845_B23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.2010.492","article-title":"Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial","volume":"79","year":"2011","journal-title":"Kidney Int"},{"issue":"2","key":"key20220906080845_B24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","year":"2009","journal-title":"Transplantation"},{"issue":"3","key":"key20220906080845_B25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1600-6143.2006.01645.x","article-title":"Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study","volume":"7","year":"2007","journal-title":"Am J Transplant"},{"issue":"6","key":"key20220906080845_B26","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1046\/j.1523-1755.2002.00361.x","article-title":"Predictors of renal function following lung or heart-lung transplantation","volume":"61","year":"2002","journal-title":"Kidney Int"},{"issue":"21","key":"key20220906080845_B27","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"issue":"9","key":"key20220906080845_B28","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/j.1600-6143.2006.01403.x","article-title":"BK virus infection in transplant recipients: an overview and update","volume":"6","year":"2006","journal-title":"Am J Transplant"},{"issue":"4","key":"key20220906080845_B29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00042560-199904010-00005","article-title":"Effect of renal disease and hemodialysis on foscarnet pharmacokinetics and dosing recommendations","volume":"20","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"2 Suppl 1","key":"key20220906080845_B30","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"key20220906080845_B31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"key20220906080845_B32","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","year":"2006","journal-title":"Am J Transplant"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T12:09:27Z","timestamp":1662466167000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1122\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,9,6]]}},"alternative-id":["10.14797\/mdcvj.1122"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1122","relation":{},"ISSN":["1947-6108"],"issn-type":[{"value":"1947-6108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}